Watch and Wait Trial
Watch and Wait is a randomised phase III trial to determine whether initial treatment with rituximab in patients with advanced stage asymptomatic follicular lymphoma (grades 1, 2 and 3a) results in a significant delay in the initiation of chemotherapy or radiotherapy and the impact of each strategy on patient-related quality of life. 360 patients randomised to receive either Rituximab treatment and maintenance or to a Watch and Wait strategy. Samples collected for trial: Formalin fixed paraffin embedded tumour block or unstained slides (lymph node and bone marrow)- sent to HMDS. Blood and bone marrow sample taken at baseline and if patient in CR clinically and radiologically at 7, 13 and 25 months - sent to University College London Hospital
Existing samples:
- Malignant lymphoma (disorder)
Contact Information
- Email:
- ctc.watchandwait@ucl.ac.uk
- Address:
-
CR UK & UCL Cancer Trials Centre
90 Tottenham Cour Road
London
Greater London
W1T 4TJ
England
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |